Skip to content

Medline, Inc. MDLN Debt-to-equity

Debt-to-equity at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.6×-0.1×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
0.1×0.0×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
0.0×
STERIS logo
STERISSTE
0.3×-0.1×
Abbott logo
AbbottABT
0.7×+0.4×
Medtronic logo
MedtronicMDT
0.6×0.0×

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$30.8B
Enterprise value$41.12B
P/E36.6×
P/S1.2×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp

Returns & leverage

See full
Return on equity7.7%
Current ratio4.4×

Where this comes from

Calculated from Medline, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's debt-to-equity?
Medline, Inc. (MDLN) reported debt-to-equity of 1.1× in Q1 2026.
What does debt-to-equity mean?
How much debt the company carries for every dollar of shareholder equity.
How do you interpret debt-to-equity?
Lower is generally safer, but moderate leverage can boost returns. Read in the context of cash-flow stability — a utility tolerates more debt than a cyclical. Negative equity makes the ratio meaningless and it is suppressed there.
How does debt-to-equity compare across companies?
Comparable within an industry; capital structures differ sharply across sectors. Not meaningful for banks.